Sign in / Join Now
ETFs & Funds
also reporting disapointing phase 2 study of imetelstat, shares down -48% pre-market
OUCH! was the recent run just a pump n dump?
Add a reply...
Latest StockTalks »
people get GERN breaking news and analysis by email alert.
Get email alerts on GERN »
Get latest price
From other sites
Geron Announces Conference Call To Discuss Third Quarter 2016 Financial Results
at TheStreet (Wed, 7:30AM)
The Zacks Analyst Blog Highlights: VIVUS, Geron, Achillion Pharmaceuticals, Anika Therapeutics and ANI Pharmaceuticals
at Zacks.com (Oct 5, 2016)
Global Licensing Deal Spikes Geron Stock (GERN, JNJ)
at Investopedia (Sep 23, 2016)
Geron (GERN) Stock Rises on $80 Million Janssen Licensing Deal
at TheStreet (Sep 19, 2016)
A Chronology Of Geron's Imetelstat
at Benzinga (Sep 14, 2016)